Clinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell Lymphoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

March 12, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

February 29, 2028

Conditions
Diffuse Large Cell B-lymphoma
Interventions
DRUG

TQB2825 Injection + Gemcitabine Hydrochloride for Injection + Oxaliplatin for Injection

"Drug: TQB2825 Injection + Gemcitabine Hydrochloride for Injection + Oxaliplatin for Injection;~Other Name:~Gemcitabine Hydrochloride for Injection, Zefei; Oxaliplatin for Injection, Aihen~TQB2825 injection is Cluster of Differentiation 3 (CD3) and and Cluster of Differentiation 20 (CD20) bispecific antibody; Gemcitabine hydrochloride for injection is a cell cycle-specific antimetabolite; Oxaliplatin for Injection is a platinum chemotherapy drug."

Trial Locations (24)

116000

RECRUITING

The Second Affiliated Hospital of Dalian Medical University, Dalian

150081

NOT_YET_RECRUITING

Harbin Medical University Cancer Hospital, Harbin

210000

NOT_YET_RECRUITING

Nanjing Drum Tower Hospital, Nanjing

215006

NOT_YET_RECRUITING

The First Affiliated Hospital of Soochow University, Suzhou

241001

NOT_YET_RECRUITING

The First Affiliated Hospital of Wannan Medical College, Wuhu

250117

NOT_YET_RECRUITING

Shandong cancer hospital, Jinan

264499

NOT_YET_RECRUITING

Weihai Central Hospital, Weihai

310000

NOT_YET_RECRUITING

THE First Affiliated Hospital ZheJiang University School of Medicine, Hangzhou

330029

NOT_YET_RECRUITING

Jiangxi Cancer Hospital, Nanchang

361003

NOT_YET_RECRUITING

The First Affiliated Hospital of Xiamen University, Xiamen

410000

NOT_YET_RECRUITING

Hunan Cancer Hospital, Changsha

410011

NOT_YET_RECRUITING

The Second Xiangya Hospital of Central South University, Changsha

430079

NOT_YET_RECRUITING

Hubei Cancer Hospital (HBCH), Wuhan

434000

NOT_YET_RECRUITING

Zhongnan Hospital of Wuhan University, Wuhan

450008

NOT_YET_RECRUITING

Henan Cancer Hospital, Zhengzhou

450052

NOT_YET_RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

510095

NOT_YET_RECRUITING

Affiliated Cancer Hospital and insititute Guangzhou Medical University, Guangzhou

530021

NOT_YET_RECRUITING

Guangxi Medical University Cancer Hospital, Nanning

610072

NOT_YET_RECRUITING

Sichuan Provincal People's Hospital, Chengdu

646000

NOT_YET_RECRUITING

The Affiliated Hospital of Southwest Medical University, Luzhou

710061

NOT_YET_RECRUITING

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

730050

NOT_YET_RECRUITING

Gansu Provincial Cancer Hospital, Lanzhou

050011

NOT_YET_RECRUITING

The Fourth Hospital of Hebei Medical University, Shijiazhuang

030000

NOT_YET_RECRUITING

Shanxi Provincial Cancer Hospital, Taiyuan

All Listed Sponsors
lead

Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

INDUSTRY